Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Med Parazitol (Mosk) ; (1): 26-9, 1998.
Article in Russian | MEDLINE | ID: mdl-9608206

ABSTRACT

The reversing action of anthelminthic praziquantel (P) on the effect of chloroquine (C) and compound R-70-Zh (styrylquinazoline) was revealed on a Plasmodium berghei model (white inbred mice), using a LNK65 isolate with naturally reduced sensitivity to chloroquine and its polyresistant line LNK65CHLFR with acquired resistance to chloroquine/fansidar (selected in our laboratory). P (125 mg/kg) in combination with C showed a potentiating effect not only on the LNK65 isolate, but also on the LNK65CHLFR line, while investigated separately on this line, both drugs were not effective in tested doses. Moreover, the similar effect of C on the LNK65CHLFR line was achieved in the dose that was 4 times higher than that of P/C combination. P in a standard dose on the LNK65 isolate showed a more marked activation of compound R-70-Zh that on C. The potentiating effect was manifested in combination with R-70-Zh in the dose half as high as that of C; this phenomenon was also reflected by the efficiency index (5.0 against the 4.0) accepted in our laboratory and may be associated with the higher sensitivity of the LNK65 isolate to R-70-Zh. P showed some antimalarial action which manifested itself only by morphological changes on P. berghei parasites similar to those observed under the action of some dihydropholate reductase inhibitors, such as pyrimethamine.


Subject(s)
Antimalarials/antagonists & inhibitors , Antiplatyhelmintic Agents/pharmacology , Calcium Channel Blockers/pharmacology , Chloroquine/antagonists & inhibitors , Drug Resistance, Multiple , Plasmodium berghei/drug effects , Praziquantel/pharmacology , Quinazolines/antagonists & inhibitors , Styrenes/antagonists & inhibitors , Animals , Antimalarials/therapeutic use , Antiplatyhelmintic Agents/therapeutic use , Calcium Channel Blockers/therapeutic use , Chloroquine/therapeutic use , Drug Combinations , Drug Evaluation, Preclinical , Drug Synergism , Malaria/drug therapy , Malaria/parasitology , Mice , Plasmodium berghei/isolation & purification , Praziquantel/therapeutic use , Pyrimethamine/antagonists & inhibitors , Quinazolines/therapeutic use , Styrenes/therapeutic use , Sulfadoxine/antagonists & inhibitors
2.
Med Parazitol (Mosk) ; (1): 18-22, 1996.
Article in Russian | MEDLINE | ID: mdl-8700004

ABSTRACT

The reversing action of verapamil on the effect of chloroquine was found in in vivo experiments by using a model P. berghei resistant to chloroquine, an LNK65 isolate having a naturally lower resistance to the agent, and its polyresistant strain with the acquired resistance to chloroquine and fansidar, as well as by employing the chlorine-resistant P. falciparum isolates from the south of the Socialist Republic of Vietnam. The magnitude of this effect was related to the dose of verapamil, the frequency of administration of a combination of the agents in vivo, while that was associated to the concentration of verapamil and the level of isolate resistance to chloroquine in vitro which was the most pronounced. Taking into account the dose-dependent effect of verapamil, it can be suggested that increasing its concentration in combination with chloroquine can provide a more marked reversing action with lower chloroquine concentrations. The parameters accepted by the authors in evaluating the combined effect enable the effect of the verapamil/chloroquine concentration to be regarded as potentiation.


Subject(s)
Antimalarials/antagonists & inhibitors , Calcium Channel Blockers/pharmacology , Chloroquine/antagonists & inhibitors , Plasmodium berghei/drug effects , Plasmodium falciparum/drug effects , Verapamil/pharmacology , Animals , Antimalarials/therapeutic use , Calcium Channel Blockers/therapeutic use , Chloroquine/therapeutic use , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Drug Interactions , Drug Resistance , Drug Therapy, Combination , Humans , Malaria/drug therapy , Malaria/parasitology , Malaria, Falciparum/parasitology , Mice , Plasmodium berghei/isolation & purification , Plasmodium falciparum/isolation & purification , Verapamil/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...